170811 ⎘
Detection or diagnosis of diseases; Musculoskeletal or connective tissue disorders; Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
METHODS AND KITS FOR DIAGNOSING OR MONITORING AUTOIMMUNE AND CHRONIC INFLAMMATORY DISEASES
#302Methods and Systems for Diagnosis of Non-Central Nervous System (CNS) Diseases in CNS Samples
#303NOVEL APPLICATION OF AIMP1 POLYPEPTIDE
#304Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
#305SELECTIVE DIFFERENTIATION, IDENTIFICATION, AMD MODULATION OF HUMAN TH17 CELLS
#306Methods and compositions related to acetylocholine receptor conjugates
#307NOVEL DIAGNOSTIC METHOD
#308BIOMARKERS FOR PREDICTING THE DEVELOPMENT OF CHRONIC AUTOIMMUNE DISEASES
#309Biomarkers for rheumatoid arthritis
#310LUPUS ANTICOAGULENT TESTING
#311Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#312COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
#313Use application of sugar chain-recognizing receptor
#314COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND AUTO-IMMUNE DISEASES
#315METHODS FOR MODIFYING, ISOLATING, DETECTING, VISUALIZING, AND QUANTIFYING CITRULLINATED AND/OR HOMOCITRULLINATED PEPTIDES, POLYPEPTIDES AND PROTEINS
#316COMPOSITIONS INCLUDING GINGER FOR THE AMELIORATION OR PREVENTION OF INFLAMMATORY CONDITIONS
#317Biomarkers and methods for measuring and monitoring inflammatory disease activity
#318Method to assess the severity of rheumatoid arthritis by measuring anti-CCP and serum amyloid A
#319Fibrosuppressant Biotherapeutics
#320METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES
#321Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
#322Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same
#323Synthetic peptides immuno-reactive with rheumatoid arthritis auto-antibodies
#324PREVENTION AND TREATMENT OF PAIN USING ANTIBODIES TO LYSOPHOSPHATIDIC ACID
#32514-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
#326Methods for treating, diagnosing, and monitoring rheumatoid arthritis
#327Fibrinogen immune complexes to diagnose and guide therapy in rheumatoid arthritis
#328Method For Determining The Type of an Inflammatory-Rheumatic Disease in Synovial Fluid
#329FSTL-1 as a biomaker of inflammation
#330Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#331METHOD OF DETECTING CALCIFYING NANOPARTICLES AND SUSCEPTIBILITY TO CALCIFYING NANOPARTICLE INFORMATION
#33214-3-3 Antagonists for the Prevention and Treatment of Arthritis
#333Method of diagnosing mild osteoarthritis
#334ASSAYS FOR CLINICAL ASSESSMENTS OF RHEUMATOID ARTHRITIS
#335METHOD FOR THE IMMOBILIZATION OF A CAPTURE MOLECULE ON A SOLID SUPPORT
#336MARKER FOR DETECTION OF IL-17-PRODUCING HELPER T-CELL, AND METHOD FOR DETECTION OF IL-17-PRODUCING HELPER T-CELL
#337METHODS AND MATERIALS FOR TREATING INFLAMMATORY CONDITIONS
#338THERAPEUTIC AND DIAGNOSTIC USES OF ANTIBODY SPECIFICITY PROFILES
#339METHOD OF DIAGNOSTIC RHEUMATOID ARTHRITIS BY SUGAR CHAIN ANALYSIS
#340Galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
#341Naphthalene-based inhibitors of anti-apoptotic proteins
#342Method for diagnosing rheumatoid arthritis via assaying myofibroblast-like synoviocytes for fibroblast activation protein
#343MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS AND USE THEREOF
#344Method for the treatment of rheumatoid arthritis using a TLR2 antagonistic antibody
#345GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF
#346MARKER SPECIFIC TO AN OXIDATIVE DEGRADATION OF TISSUES CONTAINING TYPE III COLLAGEN, MEANS AND METHODS AND KITS FOR THE DIAGNOSIS, MONITORING OR PROGNOSIS OF PATHOLOGIES TARGETED BY THIS MARKER
#347Pharmaceutical peptides for the treatment of inflammatory diseases
#348Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis
#349Citrullinated fibrin-filaggrin chimeric polypeptide capable of detecting the antibodies generated in rheumatoid arthritis
#350METHOD AND COMPOSITION FOR TREATING IMMUNE COMPLEX ASSOCIATED DISORDERS
#351Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody
#352Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease
#353MATRIX MARKER MODEL AND METHODS FOR ASSESSING AND TREATING ARTHRITIS AND RELATED DISORDERS
#354Assays For Clinical Assessments of Disease-Associated Autoantibodies
#355Candidates against infection
#356Kits for biomarker detection and treatment selection
#357Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
#358PROTEIN KINASE C ZETA AS A DRUG TARGET FOR ARTHRITIS AND OTHER INFLAMMATORY DISEASES
#359Biomarker in Inflammatory Diseases
#360Method for Identifying an Agent that Modulates Arginine Transport in a Chondrocyte
#361Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis
#362LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS
#363Use of at least one isoform of progesterone receptor membrane component 1 (PGRMC1)
#364MUTATIONS IN CAPILLARY MORPHOGENESIS GENE-2 (CMG-2) AND USE THEREOF
#365Methods for Identifying FZD8 Modulators and the Use of such Modulators for Treating Osteoarthritis
#366Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1)
#367Levels of APRIL in serum and use in diagnostic methods
#368Use of A33 antigens and JAM-IT
#369Assessing risk of disease progression in rheumatoid arthritis patients
#370PREDICTION OF AN INDIVIDUAL'S RISK OF DEVELOPING RHEUMATOID ARTHRITIS
#371Galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
#372Identification methods for ergothioneine transporter modulators and therapeutic uses thereof
#373EXPRESSION OF ORPHAN GPR64 IN INFLAMMATORY DISEASES
#374Methods and products for evaluating an immune response to a therapeutic protein
#375Rheumatoid Arthritis Test Method and Treating Method
#376Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#377DIAGNOSTIC METHOD AND PROGNOSTIC TOOL FOR RHEUMATOID ARTHRITIS
#378METHODS FOR DETERMINING THE ACTIVITY OF ADAM-TS PROTEASES USING THIOPEPTOLIDES
#379Biomarkers for the diagnosis of autoimmune disease
#380Method for the diagnosis of rheumatoid arthritis
#381Predicting and diagnosing patients with autoimmune disease
#382USE OF HISTOGRANIN AND HISTOGRANIN-LIKE COMPOUNDS AS INHIBITORS OF P2X7 RECEPTOR FUNCTION AND AS ANTI-ARTHRITIC AGENTS
#383Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases
#384Detection and treatment of autoimmune disorders
#385Ascorbic acid conjugates
#386Bone/joint disease sensitivity gene and use thereof
#387Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases
#388Immunogenic fragments of T-cell receptor constant domains and peptides derived therefrom
#389Uses and compositions for treatment of psoriatic arthritis
#390Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
#391Novel Integrin Ligand ITGL-TSP
#392Use of A33 antigens and JAM-it
#393Immunoassay methods
#394Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer
#395Method of detecting early immune activation
#396Use of Serum/Glucocorticoid-Regulated Kinase
#397AUTOIMMUNE DISEASE BIOMARKERS
#398Inflammation treatment, detection and monitoring via TREM-1
#399Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions
#400Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
#401Method of Detecting or Differentiating Rheumatoid Arthritis and Method of Determining Stage of Disease or Degree of Dysfunction with Regard to Rheumatoid Arthritis
#402Dampening Humoral and Innate Immunity by Inhibition of Ppgalnact-1
#403COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
#404TREATING AND EVALUATING INFLAMMATORY DISORDERS
#405Compositions and methods for treating inflammation and auto-immune diseases
#406MICROARRAY-BASED ANALYSIS OF RHEUMATOID ARTHRITIS MARKERS
#407Uses and compositions for treatment of juvenile rheumatoid arthritis
#408Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis
#409Methods of diagnosing synovial disease in a mammal by detecting bacterial DNA in synovial tissues from dogs with inflammatory knee arthritis and degenerative anterior cruciate ligament rupture
#410Use Of Resistin Antisense Oligonucleotides And/Or Sirna Molecules In The Treatment Of Rheumatoid Arthritis
#411Antibody specific for a chondroitin sulphate epitope
#412Antibody profiling for determination of patient responsiveness
#413Modulation of Programmed Necrosis
#414Compositions and Methods of Use for a Fibroblast Growth Factor
#415Combined measurement of anti-CCP and serum amyloid A to assess rheumatoid arthritis
#416Uncoupled collagen synthesis and degradation assays
#417Methods of diagnosing and treating rheumatoid arthritis and osteoarthritis
#418Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3
#419Methods for assessing the efficacy of treatment with a glucocorticoid
#420Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention
#421ISLR gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof
#422ASSAYS AND PEPTIDE SUBSTRATE FOR DETERMINING AGGRECAN DEGRADING METALLO PROTEASE ACTIVITY
#423Use of A33 antigens and JAM-IT
#424Triple polypeptide complexes
#425Anti-CCPand antinuclear antibodies in diagnosis of rheumatoid arthritis
#426Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis
#427Methods of treating cancer, arthritis and/or diabetes with angiopoietins
#428Novel ubp8rp polypeptides and their use in the treatment of psoriasis
#429OPIATE, CANNABINOID, AND ESTROGEN RECEPTORS
#430Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#431Method of assessing rheumatoid arthritis by measuring rheumatoid factor and interleukin-6
#432Use of A33 antigens and jam-it
#433Novel Integrin Ligand ITGL-TSP
#434Novel Integrin Ligand ITGL-TSP
#435Lupus anticoagulant testing
#436Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
#437Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
#438Methods and compositions related to joint inflammation diseases
#439High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases
#440Mild osteoarthritis biomarkers and uses thereof
#441Methods and systems for diagnosis of non-central nervous system (cns) diseases in cns samples
#442Use of A33 antigens and JAM-it
#443Immunologic activity measures for t helper on-associated conditions
#444Method for measuring spinorphin
#445Diagnostic and therapeutic agents for rheumatoid arthritis
#446IL-ILI gene and polypeptide products
#447Method for diagnosis of rheumatoid arthritis
#448Use of glucose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
#449Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis
#450Microarray-based analysis of rheumatoid arthritis markers
#451Method of treating multiple sclerosis with anti-K6 antibody
#452Methods of identifying and isolating cells expressing DC-sign
#453Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#454Method of treatment and prophylaxis
#455HM74 and HM74a in cuboidal endothelial cells as associated with inflammation
#456Isolated antibodies immunoreactive with synthetic peptides used to detect rheumatoid arthritis
#457Use of TF antagonists
#458Isolated T lymphocyte receptors specific for human autoantigens complexed with human MHC molecules and methods of making and using same
#459Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
#460Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
#461Remedies or preventives for rheumatoid arthritis
#462Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-1
#463Stratification of patient populations having or suspected of having rheumatoid arthritis
#464Mutations in capillary morphogenesis gene-2 (CMG-2) and use thereof
#465Novel integrin ligand ITGL-TSP
#466Treatment of rheumatoid arthritis with FLIP antagonists
#467Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis
#468Disease susceptibility gene for rheumatoid arthritis, protein thereof, evaluation method and evaluation kit for evaluating onset possibility of rheumatoid arthritis by using those, and remedy and curing medicine for rheumatoid arthritis
#469Compositions, kits, and methods for identification, assessment, prevention, and therapy of Rheumatoid Arthritis
#470Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating
#471Method and composition for treating immune complex associated disorders
#472Isle gene and its association with osteoarthritis and other bone and cartilage disorders expression products derived therefrom and uses thereof
#473Method to diagnose and treat degenerative joint disease